|
Jun 11
|
We're Not Very Worried About Y-mAbs Therapeutics' (NASDAQ:YMAB) Cash Burn Rate
|
|
May 28
|
Y-mAbs Hosts Virtual Radiopharmaceutical R&D Update Highlighting Clinical Progress and Expanded Pipeline
|
|
May 27
|
Y-mAbs Therapeutics, Inc. (YMAB) Unveils Promising Cancer Trial Data at ANR 2025
|
|
May 26
|
Y-mAbs Presents GD2-SADA PRIT Trial in Progress Poster at the Advances in Neuroblastoma Research Meeting
|
|
Apr 30
|
Earnings Preview: Acadia Pharmaceuticals (ACAD) Q1 Earnings Expected to Decline
|
|
Apr 29
|
Earnings Preview: Y-mAbs Therapeutics, Inc. (YMAB) Q1 Earnings Expected to Decline
|
|
Apr 27
|
Y-mAbs Presents Translational Pharmacokinetics of CD38-SADA from Pretargeted RIT Platform at 2025 American Association for Cancer Research (AACR) Annual Meeting
|
|
Apr 27
|
Y-mAbs Therapeutics, Inc.'s (NASDAQ:YMAB) latest 13% decline adds to one-year losses, institutional investors may consider drastic measures
|
|
Apr 25
|
Y-mAbs Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating CD38-SADA Pre-targeted Radioimmunotherapy in Relapsed/Refractory Non-Hodgkin Lymphoma
|
|
Mar 9
|
Bearish: Analysts Just Cut Their Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Revenue and EPS estimates
|
|
Feb 20
|
Y-mAbs to Announce Fourth Quarter and Full Year 2024 Financial and Operating Results on March 4, 2025
|
|
Oct 1
|
Y-mAbs to Participate in Upcoming Investor Conferences in October
|
|
Sep 25
|
While shareholders of Y-mAbs Therapeutics (NASDAQ:YMAB) are in the black over 1 year, those who bought a week ago aren't so fortunate
|
|
Sep 3
|
Y-mAbs to Participate in Upcoming Investor Conferences in September
|
|
May 9
|
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q1 2024 Earnings Call Transcript
|
|
May 9
|
Y-mAbs Therapeutics Inc (YMAB) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
|
|
May 9
|
Q1 2024 Y-mAbs Therapeutics Inc Earnings Call
|
|
May 7
|
Y-mAbs Therapeutics Reports Q1 2024 Results: Aligns with EPS Projections, Misses Revenue Estimates
|
|
May 7
|
Y-mAbs Therapeutics, Inc. (YMAB) Reports Q1 Loss, Misses Revenue Estimates
|
|
May 7
|
Y-mAbs Reports First Quarter 2024 Financial Results and Recent Corporate Developments
|